Skip to main content

Table 2 Prevalence of anti-CarP, ACPA and RF in RA patients, disease controls and healthy subjects

From: Erratum to: Prevalence, sensitivity and specificity of antibodies against carbamylated proteins in a monocentric cohort of patients with rheumatoid arthritis and other autoimmune rheumatic diseases

Disease

(No of patients)

Anti-CarP positive n, (%)

ACPA positive n, (%)

RF positive n, (%)

RA (309)

117 (37.9)

190 (61.4)

202 (65.3)

NHS (98)

2 (2.04)

1 (1.02)

3 (3.06)

SLE (83)

14 (16.8)

15 (18.07)

19 (22.8)

SS (45)

14 (31.1)

11 (24.4)

23 (51.1)

SSc (51)

3 (5.8)

1 (1.9)

18 (35.2)

OP (21)

2 (9.5)

2 (9.5)

4 (19.04)

  1. Anti-CarP anti-carbamylated proteins antibodies, ACPA anti-citrullinated peptides antibodies, RF rheumatoid factor, RA Rheumatoid Arthritis, NHS Normal Healthy Subjects, SLE Systemic Lupus Erythematosus, SS Sjögren Syndrome, SSc Systemic Sclerosis, OP osteoporosis
Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us